null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Chronic Myeloproliferative Disorders

List Price: $189.99
SKU:
9780415415989
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Tariq Mughal, John M. Goldman
    Format:
    Hardcover
    Pages:
    272
    Publisher:
    CRC Press (August 27, 2008)
    Imprint:
    CRC Press
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9780415415989
    Weight:
    21.875oz
    Dimensions:
    7.4375" x 9.6875"
    File:
    TAYLORFRANCIS-TayFran_261003042832725-20261003.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $189.99
    Country of Origin:
    United States
    Pub Discount:
    30
    Case Pack:
    28
    As low as:
    $180.49
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
  • Overview

    With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.

    This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.